Is this actually your fit?
Two short trait quizzes scored against this exact role. No signup, no card. Honest answer in 4 minutes.
Every career on ClarUp carries a 6-trait blueprint scored from real practitioners. Take the 3-min DNA test to see your fit.
High Conscientiousness93/100
The strongest signal for this role. People who score 70+ on this dimension report higher day-to-day satisfaction.
India-first salary signal — fresh-grad to senior, the cities where it pays best, and what each level is worth on the open market.
Numbers reflect open-market hires at the level shown.
Equity, bonuses, and overtime are not included. Senior-bracket numbers can rise 30–60% at top studios / tier-1 firms; smaller cities trend 20% lower than metros.
Largest PV hub in India — Cognizant LifeSciences, Accenture PV, Dr. Reddy's PV, IQVIA, Syneos Health all have large PV operations in Madhapur/Gachibowli. Freshers ₹3-5L; senior associates ₹8-15L; team leads ₹18-35L.
TCS BPS, Wipro PV, Accenture PV, and in-house GSK/AstraZeneca PV teams. 10-15% premium over Hyderabad for equivalent experience. Signal specialists and PV managers ₹25-40L.
Pfizer India, Novartis, Sanofi, Sun Pharma in-house PV. Highest pay for experienced PV professionals — Head of Drug Safety at MNC pharma ₹40-75L. KPO entry roles similar to Bengaluru.
Cognizant LifeSciences, ICON, Parexel, and Serum Institute PV teams. Mid-sized cluster; team lead roles ₹15-25L.
Smaller PV cluster — some TCS BPS and CRO operations. Pay slightly below Hyderabad for equivalent roles.
Not the brochure version. The actual block-by-block reality of the role on a typical Tuesday.
Log in to Oracle Argus Safety, check overnight case queue, and review follow-up responses received from US/EU reporters. Flag any cases approaching Day 12 of the 15-day expedited window so the team lead can prioritise.
Team stand-up: PV lead reviews daily case throughput KPIs and flags expedited cases at risk of missing the USFDA/EMA Day-15 deadline. Associates confirm case ownership and expected completion time for each open serious case.
Process three serious ICSRs end-to-end — enter patient demographics, drug data, and event details into Argus Safety; code adverse events in MedDRA browser (verify LLT → PT hierarchy); classify seriousness per ICH E2A criteria (death, life-threatening, hospitalisation, congenital anomaly, or medically significant).
Write case narratives for two completed ICSRs — synthesise medical records, reporter statements, and lab data into structured 400-word chronological narratives meeting ICH E2B and EMA/USFDA requirements. Submit to senior associate for QC review.
Lunch break followed by a 30-minute internal MedDRA 26.1 version-update training session. Twice-yearly MedDRA releases require mandatory retraining — skipping can invalidate a coding batch.
Literature surveillance: run pre-validated PubMed/Embase search strings for the product portfolio, screen 14 abstracts, retrieve 2 case-qualifying full texts, and create literature ICSRs in Argus for qualifying serious publications. QC two associate ICSRs — check MedDRA coding accuracy, seriousness classification, company causality, and E2B field completeness.
Submit validated E2B(R3) XML to EMA EudraVigilance gateway for two 15-day serious unexpected cases; confirm acknowledgement receipts from the portal. Update PSUR line listing with the week's new ICSRs flagged by seriousness and expectedness, cross-checking denominator data with the clinical team. Queue review for next day; log off by 6:30 PM.
Cost, time, and what each path actually buys you in the hiring market.
Fastest paid hire route
Cheapest · portfolio is your degree
Core skills you must own, the support skills you'll grow into, and the tools you'll have open all day.
People already doing this work — and the rooms (subreddits, Discords, Slacks) where they hang out.
Dr. Y.K. Gupta
Former Head, PvPI National Coordination Centre · AIIMS / IPC Ghaziabad
Dr. Shashi Bala Singh
Former Director General · Indian Pharmacopoeia Commission (IPC)
Cognizant LifeSciences PV India cohort
Drug Safety Associates and PV Officers · Cognizant LifeSciences, Hyderabad and Chennai
IPC Ghaziabad PvPI AMC Network
Pharmacovigilance Coordinators · Indian Pharmacopoeia Commission / 250+ hospital AMCs
ISOP (International Society of Pharmacovigilance) India Chapter
WebThe Indian chapter of ISOP runs annual symposiums, webinars on GVP Module updates, and professional certification pathways. Membership connects Indian PV professionals with global signal detection and aggregate reporting practitioners. ISOP India events are held in Hyderabad, Bengaluru, and Mumbai annually.
PvPI India Pharmacovigilance Professionals
TelegramActive Telegram community of PV professionals across Indian KPOs (Cognizant, Accenture, TCS BPS) and in-house pharma teams. Members share CDSCO circulars, GVP module updates, MedDRA version-change notes, and job referrals. Particularly useful for tracking CDSCO inspection trends and PvPI ADR reporting regulatory updates.
Drug Safety India — LinkedIn Group
LinkedInLinkedIn professional community for Indian PV officers, drug safety associates, and regulatory affairs professionals. Members post job openings at KPOs and pharma companies, discuss USFDA/EMA regulatory updates, and share MedDRA coding tips. Strong peer network for KPO-to-in-house pharma transitions.
r/pharmacovigilance
RedditGlobal subreddit for PV professionals covering ICSR processing queries, MedDRA coding questions, signal detection methodology, and career advice. Indian context is well represented with KPO experience threads, CDSCO compliance discussions, and salary benchmarking from Hyderabad and Bengaluru.
The traps real practitioners wish someone had named for them in year one. Read these before you commit, not after.
Staying in pure ICSR processing for more than 4 years without moving to signal detection or aggregate reporting
Learning only Argus Safety and ignoring ArisG or Veeva Vault Safety
Ignoring CDSCO / PvPI regulations and focusing only on USFDA/EMA
Treating PV as a non-clinical back-office function and not building medical literature reading habits
Books, longreads, and references practitioners come back to.
Pharmacovigilance: A Practical Guide
by Patrick Waller and Mira Harrison-Woolrych
ICH E2A: Clinical Safety Data Management — Definitions and Standards for Expedited Reporting
by International Council for Harmonisation (ICH)
GVP Module VI — Management and Reporting of Adverse Reactions to Medicinal Products
by European Medicines Agency (EMA)
Drug Safety (journal)
by Springer / Adis
PvPI Annual Report
by Indian Pharmacopoeia Commission / CDSCO
Two short trait quizzes scored against this exact role — see your fit % in 4 minutes. No signup, no card.
Two short artifacts go beyond the general DNA test — a per-career simulation tests how you make real workplace decisions, and a per-career aptitude test checks your capability with the actual work. Sign in with Pro to start.
Verified this quarter
Healthcare
Operation Theatre Technicians (OT Technicians) are the backbone of every surgical team — they set up the sterile field, prepare instrument trays, manage autoclave sterilisation, and assist scrub nurses and surgeons intra-operatively. In India, the role is entered via a B.Sc OT Technology (3-year) or Diploma in OT Technician (2-year) after 12th PCB, and is in high demand at corporate chains (Apollo, Fortis, Max, Manipal), AIIMS and government district hospitals, and standalone surgical centres. Experienced technicians who specialise in Cardiac OT, Neuro OT, or Robotic-assisted surgery earn significantly higher salaries and are actively recruited to GCC countries (Saudi Arabia, UAE, Oman) on tax-free packages.
Healthcare
Pharmacists in India sit at the safety checkpoint between a doctor's prescription and the patient who will actually swallow the tablet — verifying drug dosages, flagging interactions, counselling patients on use, and in many settings being the most accessible healthcare professional in a neighbourhood. The qualification ladder runs D.Pharm (2 years) for retail / community pharmacists, B.Pharm (4 years after Class 12 with PCB / PCM) for hospital and industry roles, and M.Pharm or Pharm.D (6 years, an emerging clinical-pharmacy track) for hospital-clinical, regulatory, and R&D careers. Workplaces split sharply across three lanes: retail / community pharmacy (Apollo Pharmacy, MedPlus, Wellness Forever, neighbourhood chemists), hospital pharmacy (AIIMS, Apollo, Fortis, Manipal — drug-store, IV admixture, oncology day-care, ICU unit-dose), and industry (Sun Pharma, Cipla, Dr. Reddy's, Lupin, Pfizer India, Aurobindo) covering R&D, formulation, regulatory affairs, quality assurance, and medical affairs. State Pharmacy Council registration after qualification is mandatory before practising — and the council under the Pharmacy Act 1948 is a real, audited credential the Drug Inspector can ask for at any moment.
Healthcare
Plastic Surgeons in India operate across two interlocking practices: reconstructive surgery (burn management with split-thickness and full-thickness skin grafts, cleft lip/palate repair using Millard or Tennison-Randall techniques, free flap microsurgery for post-oncological and post-traumatic defects, hand surgery including replantation and tendon reconstruction) and cosmetic/aesthetic surgery (rhinoplasty, blepharoplasty, rhytidectomy, breast augmentation with Baker Grade monitoring, abdominoplasty, liposuction, hair transplant via FUE/FUT). The canonical path is MBBS + MS General Surgery + M.Ch Plastic Surgery (3 years via NEET-SS) at AIIMS, PGI Chandigarh, KEM Mumbai, CMC Vellore, or PGIMER — giving access to both high-volume reconstructive units (burn wards, trauma centres, cancer reconstructive teams at Tata Memorial) and a premium cosmetic practice in metro cities. Aesthetic-only clinics such as Sculpt India, Cocoona, and Anti-Clock have created a parallel high-income private track; senior cosmetic practitioners in Delhi-NCR, Mumbai, and Bengaluru clear ₹2–8 Cr annually.
Healthcare
Siddha doctors in India practise one of the oldest indigenous medical systems — rooted in the Tamil Siddhar tradition, with a 5,000-year lineage attributed to the 18 Siddhars including Agasthiyar and Yugi Munivar. The standard route is BSMS (Bachelor of Siddha Medicine and Surgery, 5.5 years including 1-year compulsory internship) from a CCIM/NCISM-recognised college, admitted through NEET-UG via AYUSH counselling. Practice centres on Mukkutram (Tridosha analogue: Vali/Vata, Azhal/Pitta, Iyam/Kapha) diagnosis through Envagai Thervu (eight-fold examination including Naadi/pulse reading, tongue, eyes, urine, stool, sound, skin, complexion), and prescription of mineral-metallic formulations: Parpam (calcined metals/minerals), Chendooram (red oxide preparations), Mezhugu (wax-based formulations), and Kashayam (decoctions). Thokkanam (classical Siddha massage and manipulative therapy) and Varmam (vital energy-point therapy) are additional procedural skills. The field is highly concentrated in Tamil Nadu — which operates the National Institute of Siddha (NIS Chennai), Arignar Anna Government Hospital of Indian Medicine, and the country's largest state AYUSH Siddha infrastructure — with secondary presence in Kerala, Andhra Pradesh, and among the Tamil diaspora in Sri Lanka and Singapore.
Healthcare
Veterinary doctors in India diagnose, treat, and prevent diseases in animals ranging from companion pets (dogs, cats, exotic birds) to livestock (buffalo, cattle, poultry), wildlife, and aquaculture. The qualifying degree is B.V.Sc & A.H. (Bachelor of Veterinary Science and Animal Husbandry, 5 years including a 6-month internship) from a VCI-recognised college, admitted via NEET-UG. Practice settings span state Animal Husbandry Departments (AHD), private small-animal hospitals in metro cities (Cessna Lifeline, CGS Hospital, Petcura network), dairy cooperative veterinary units (Amul, Nandini, Mother Dairy), poultry integrators (Suguna, Venkateshwara Hatcheries), pharma companies (Zoetis, MSD Animal Health, Elanco), and wildlife / forest departments under the MoEFCC. India's urban pet-care boom — over 32 million pet dogs alone in 2025 — has created a wave of corporate multi-specialty small-animal hospitals in tier-1 and tier-2 cities, bringing surgical specialties (orthopaedics, ophthalmology, oncology) that barely existed 10 years ago.
Healthcare
Nutritionists in India design evidence-based food, nutrient, and lifestyle plans that improve metabolic, hormonal, and chronic-disease outcomes — distinct from clinical dietitians (typically hospital-based RD-IDA-registered roles managing tube feeds, post-surgical, and ICU nutrition) by their stronger lean towards community, corporate-wellness, sports, and private-practice work. Standard routes are B.Sc Food, Nutrition & Dietetics or B.Sc Home Science (Nutrition major) followed by M.Sc Dietetics & Food Service Management or M.Sc Clinical Nutrition; the Indian Dietetic Association RD (Registered Dietitian) credential is the highest-respected India qualification. Practice settings span hospital wards (Apollo, Fortis, Manipal, Max, Medanta), corporate-wellness companies (HealthifyMe, Cure.fit, Truweight, Nourish, Possible, Cult.fit), gym and sports-nutrition consultancies, school and government nutrition programs (POSHAN, ICDS), and increasingly Instagram / YouTube-driven private clinics where a senior nutritionist can run ₹15-50L+ practices on personal-brand reach. The work blends rigorous biochemistry (macronutrient calculation, micronutrient assessment, body-composition tracking, lab-marker interpretation) with sustained behaviour-change coaching — the patient who knows what to eat is not the patient who actually eats it, and the difference is the nutritionist's craft.